Bone Biologics Corp. ROA

ROA of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROA growth rates and interactive chart. Return on Assets (ROA) is an indicator of how well a company utilizes its assets, by determining how profitable a company is relative to its total assets. A company with $1 million in net income and $10 million in average assets will have a 10% ROA.


Highlights and Quick Summary

  • Annual ROA for 2021 was -48.26% (a -99.59% decrease from previous year)
  • Annual ROA for 2020 was -11848.7% (a 1753.53% increase from previous year)
  • Annual ROA for 2019 was -639.25% (a 32.48% increase from previous year)
  • Twelve month ROA ending September 30, 2022 was 16323.11% (a 7.54% increase compared to previous quarter)
  • Twelve month trailing ROA increased by 26.79% year-over-year
Trailing ROA for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
16323.11% 15178.54% 14094.77% 12874.26%
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROA of Bone Biologics Corp.

Most recent ROAof BBLG including historical data for past 10 years.

Interactive Chart of ROA of Bone Biologics Corp.

Bone Biologics Corp. ROA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -48.26%
2020 -11848.7%
2019 -639.25%
2018 -482.51%
2017 -942.22%
2016 -3457.87%

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices